Indrayani Biotech Balance Sheet Health
Financial Health criteria checks 4/6
Indrayani Biotech has a total shareholder equity of ₹519.7M and total debt of ₹944.8M, which brings its debt-to-equity ratio to 181.8%. Its total assets and total liabilities are ₹1.8B and ₹1.3B respectively. Indrayani Biotech's EBIT is ₹129.8M making its interest coverage ratio 5.2. It has cash and short-term investments of ₹5.8M.
Key information
181.8%
Debt to equity ratio
₹944.76m
Debt
Interest coverage ratio | 5.2x |
Cash | ₹5.80m |
Equity | ₹519.71m |
Total liabilities | ₹1.27b |
Total assets | ₹1.79b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 526445's short term assets (₹925.7M) exceed its short term liabilities (₹725.8M).
Long Term Liabilities: 526445's short term assets (₹925.7M) exceed its long term liabilities (₹544.3M).
Debt to Equity History and Analysis
Debt Level: 526445's net debt to equity ratio (180.7%) is considered high.
Reducing Debt: Insufficient data to determine if 526445's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: 526445's debt is well covered by operating cash flow (39.2%).
Interest Coverage: 526445's interest payments on its debt are well covered by EBIT (5.2x coverage).